Women's Health Market Research 2023, Business Growth Analysis, Key Strategies, Revenue Status And Forecast By 2032 || AbbVie Inc., Bayer AG, Merck & Co. Inc., Pfizer Inc., Agile Therapeutics, Amgen Inc

The Business Research Company's global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company's Women's Health Global Market Report 2023 identifies the rising prevalence of women-centric diseases as the major driver for the women's health market's growth in the forecast period. The women-centric diseases such as anemia, osteoporosis, breast cancer, menopause, and others are highly occurring due to various risk factors such as family history, increasing age, early onset of periods or menopause after 55 years, obesity, and others. This rising prevalence of women-centric diseases drives demand for women's health products and services that are required to treat these diseases and ensure the health and wellness of women. For instance, the World Health Organization (WHO), a specialized institution based in Switzerland responsible for global public health, estimates that in 2020, 2.3 million women received a breast cancer diagnosis, and there will be 685,000 fatalities worldwide.

The global women's health market size is expected to grow from $39.43 billion in 2022 to $41.40 billion in 2023 at a compound annual growth rate (CAGR) of 5.0%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The women's health market size is expected to grow to $49.86 billion in 2027 at a CAGR of 4.8%.

Download Free Sample Of Women's Health Market Report -
https://www.thebusinessresearchcompany.com/sample.aspx?id=8017&type=smp

Major competitors in the women's health market are AbbVie Inc., Bayer AG, Merck & Co. Inc., Pfizer Inc., Agile Therapeutics, Amgen Inc., Apothecus Pharmaceutical Corporation, Blairex Laboratories Inc., Novartis AG, AstraZeneca plc, F. Hoffmann-La Roche Ltd., Ferring Pharmaceuticals, Lupin Pharmaceuticals Inc.

A key trend in the women's health market includes developments in women's health. Major companies operating in the women's health market are developing new products to strengthen their position. For instance, in November 2021, FemTec Health, a US-based startup that focuses on women's health and beauty using technology and data to personalize care, developed a data analytics platform and infrastructure called BiomeAI to customize care by using genetic, consumer, microbiome, and biometric data. The BiomeAI engine uses deep machine learning and AI to translate this data into the delivery of holistic healthcare personalized for every woman.

Read More On The Global Women's Health Market Report Here:
https://www.thebusinessresearchcompany.com/report/womens-health-global-market-report

The Women's Health market is segmented -

• By Product Type: Devices, Drugs, Pharmaceutical Pipeline

• By Age: 50 Years & Above; Other Ages

• By Treatment Type: Hormonal Treatment, Non-Hormonal Treatment, and Surgery

• By Application: Postmenopausal Osteoporosis, Hormonal Infertility, Endometriosis & Uterine Fibroids, Contraceptives, Menopause

• By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

• By Geography: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. North America was the largest region in the women's health market.

The Business Research Company's "Global Women's Health Market Report 2023" provides a thorough understanding of the market across 60 geographies. The report covers market size, growth rate, segments, drivers and trends in every region and country. In addition, the report offers insights on historical and forecast growth, helping players analyze and strategize better.

Explore Buying Options For The Women's Health Market Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8017

The Table Of Content For The Women's Health Market Include:
1. Executive Summary
2. Women's Health Market Characteristics
3. Women's Health Market Trends And Strategies
4. Women's Health Market - Macro Economic Scenario
5. Women's Health Market Size And Growth
……………
27. Women's Health Market Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions In The Women's Health Market
29. Women's Health Market Future Outlook And Potential Analysis
30. Appendix

Contact us:

The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx

Want To Know More About The Business Research Company?

The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database

The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.

This release was published on openPR.